![](https://scx1.b-cdn.net/csz/news/tmb/2020/apoalampltsu.jpg)
Therapy found to reduce lipoprotein(a) levels
(HealthDay)—For patients with elevated lipoprotein(a) levels and established cardiovascular disease, hepatocyte-directed antisense oligonucleotide AKCEA-APO(a)-LRX (APO(a)-LRX) reduces lipoprotein(a) levels, according to ...
Jan 3, 2020
0
5